Neurocrine Biosciences, Inc. (NASDAQ:NBIX) will hold its 2Q20 earnings conference call with the financial community on 3rd August 2020 at 4:30 PM Eastern Time.
The conference call will be webcast live on Internet at www.neurocrine.com
Earnings Expectation
Neurocrine Biosciences, Inc. is set to announce second quarter earning results on Monday 3rd August 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, NBIX to report 2Q20 income of $ 0.73 per share. For the full year, analysts anticipate top line of $ 1073.05 million, while looking forward to income of $ 2.93 per share bottom line.
Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company offers INGREZZA (valbenazine), a vesicular monoamine transporter 2 inhibitor (VMAT2), which is used for the treatment of movement disorders; ORILISSA, a gonadotropin-releasing hormone (GnRH) antagonist for use in womens health.
